{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:30:20Z","timestamp":1789875020563,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep06343","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T09:04:00Z","timestamp":1410426240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia"],"prefix":"10.1038","volume":"4","author":[{"given":"Naoya","family":"Aoshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Fujie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Tukey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"key":"BFsrep06343_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0065-3101(24)00052-5","volume":"44","author":"GR Gourley","year":"1997","unstructured":"Gourley, G. R. Bilirubin metabolism and kernicterus. Adv. Pediatr. 44, 173\u2013229 (1997).","journal-title":"Adv. Pediatr."},{"key":"BFsrep06343_CR2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.32.6.995","volume":"32","author":"AJ Newman","year":"1963","unstructured":"Newman, A. J. & Gross, S. Hyperbilirubinemia in breast-fed infants. Pediatrics 32, 995\u20131001 (1963).","journal-title":"Pediatrics"},{"key":"BFsrep06343_CR3","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1172\/JCI105078","volume":"43","author":"IM Arias","year":"1964","unstructured":"Arias, I. M., Gartner, L. M., Seifter, S. & Furman, M. Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steriod, pregnane-3(alpha), 20(beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J. Clin. Invest. 43, 2037\u20132047 (1964).","journal-title":"J. Clin. Invest."},{"key":"BFsrep06343_CR4","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1001\/jama.1986.03370230076034","volume":"255","author":"AP Schneider","year":"1986","unstructured":"Schneider, A. P. Breast milk jaundice in the newborn: A real entity. JAMA 255, 3270\u20133274 (1986).","journal-title":"JAMA"},{"key":"BFsrep06343_CR5","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297\u2013316 (2004).","DOI":"10.1542\/peds.114.1.297"},{"key":"BFsrep06343_CR6","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1542\/peds.114.1.e130","volume":"114","author":"S Ip","year":"2004","unstructured":"Ip, S. et al. An Evidence-Based Review of Important Issues Concerning Neonatal Hyperbilirubinemia. Pediatrics 114, e130\u2013e153 (2004).","journal-title":"Pediatrics"},{"key":"BFsrep06343_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1542\/peds.2009-0329","volume":"124","author":"MJ Maisels","year":"2009","unstructured":"Maisels, M. J. et al. Hyperbilirubinemia in the newborn infant > or = 35 weeks' gestation: an update with clarifications. Pediatrics 124, 1193\u20131198 (2009).","journal-title":"Pediatrics"},{"key":"BFsrep06343_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jpeds.2014.01.060","volume":"165","author":"Y Maruo","year":"2014","unstructured":"Maruo, Y. et al. Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice. J Pediatr. 165, 36\u201341 (2014).","journal-title":"J Pediatr."},{"key":"BFsrep06343_CR9","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1038\/srep02903","volume":"3","author":"A Shibuya","year":"2013","unstructured":"Shibuya, A., Itoh, T., Tukey, R. H. & Fujiwara, R. Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia. Sci. Rep. 3, 2903 (2013).","journal-title":"Sci. Rep."},{"key":"BFsrep06343_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.gastro.2011.09.045","volume":"142","author":"R Fujiwara","year":"2012","unstructured":"Fujiwara, R., Chen, S., Karin, M. & Tukey, R. H. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kB leads to hyperbilirubinemia. Gastroenterology 142, 109\u201318 (2012).","journal-title":"Gastroenterology"},{"key":"BFsrep06343_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0022-3476(77)80714-2","volume":"90","author":"KL Tan","year":"1977","unstructured":"Tan, K. L. The nature of the dose-response relationship of phototherapy for neonatal hyperbilirubinemia. J. Pediatr. 90, 448\u2013452 (1977).","journal-title":"J. Pediatr."},{"key":"BFsrep06343_CR12","first-page":"102","volume":"85","author":"S Wananukul","year":"2002","unstructured":"Wananukul, S. & Praisuwanna, P. Clear topical ointment decreases transepidermal water loss in jaundiced preterm infants receiving phototherapy. J. Med. Assoc. Thai. 85, 102\u2013106 (2002).","journal-title":"J. Med. Assoc. Thai."},{"key":"BFsrep06343_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13312-010-0020-7","volume":"47","author":"P Kumar","year":"2010","unstructured":"Kumar, P. et al. Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi center randomized controlled trial. Indian. Pediatr. 47, 131\u2013137 (2010).","journal-title":"Indian. Pediatr."},{"key":"BFsrep06343_CR14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.32.6.995","volume":"32","author":"AJ Newman","year":"1963","unstructured":"Newman, A. J. & Gross, S. Hyperbilirubinemia in breast-fed infants. Pediatrics. 32, 995\u20131001 (1963).","journal-title":"Pediatrics."},{"key":"BFsrep06343_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/jhg.2012.116","volume":"58","author":"H Sato","year":"2013","unstructured":"Sato, H. et al. Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding. J. Hum. Genet. 58, 7\u201310 (2013).","journal-title":"J. Hum. Genet."},{"key":"BFsrep06343_CR16","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","volume":"269","author":"PJ Bosma","year":"1994","unstructured":"Bosma, P. J. et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem. 269, 17960\u201317964 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06343_CR17","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1073\/pnas.0913290107","volume":"107","author":"R Fujiwara","year":"2010","unstructured":"Fujiwara, R., Nguyen, N., Chen, S. & Tukey, R. H. Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus. Proc. Natl. Acad. Sci. U.S.A. 107, 5024\u20139 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"BFsrep06343_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1124\/dmd.108.021428","volume":"36","author":"A Nakamura","year":"2008","unstructured":"Nakamura, A., Nakajima, M., Yamanaka, H., Fujiwara, R. & Yokoi, T. Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab. Dispos. 36, 1461\u20131464 (2008).","journal-title":"Dispos."},{"key":"BFsrep06343_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF02796440","volume":"12","author":"BH Tom","year":"1976","unstructured":"Tom, B. H. et al. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 12, 180\u201391 (1976).","journal-title":"In Vitro"},{"key":"BFsrep06343_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jps.2600790604","volume":"79","author":"P Artursson","year":"1990","unstructured":"Artursson, P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79, 476\u201382 (1990).","journal-title":"J. Pharm. Sci."},{"key":"BFsrep06343_CR21","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1016\/S0021-9258(18)82429-2","volume":"268","author":"J Hunter","year":"1993","unstructured":"Hunter, J., Jepson, M. A., Tsuruo, T., Simmons, N. L. & Hirst, B. H. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268, 14991\u201314997 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06343_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00756522","volume":"11","author":"V Meunier","year":"1995","unstructured":"Meunier, V., Bourri\u00e9, M., Berger, Y. & Fabre, G. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 11, 187\u201394 (1995).","journal-title":"Cell Biol. Toxicol."},{"key":"BFsrep06343_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0006-2952(99)00133-1","volume":"58","author":"UK Walle","year":"1999","unstructured":"Walle, U. K., Galijatovic, A. & Walle, T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem Pharmacol. 58, 431\u20138 (1999).","journal-title":"Biochem Pharmacol."},{"key":"BFsrep06343_CR24","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1053\/j.gastro.2008.02.076","volume":"134","author":"T Li","year":"2008","unstructured":"Li, T., Bai, L., Li, J., Igarashi, S. & Ghishan, F. K. Sp1 is required for glucose-induced transcriptional regulation of mouse vesicular glutamate transporter 2 gene. Gastroenterology. 134, 1994\u20132003 (2008).","journal-title":"Gastroenterology."},{"key":"BFsrep06343_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s005350070044","volume":"35","author":"T Kamisako","year":"2000","unstructured":"Kamisako, T. et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol. 35, 659\u2013664 (2000).","journal-title":"J Gastroenterol."},{"key":"BFsrep06343_CR26","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","volume":"95","author":"E Beutler","year":"1998","unstructured":"Beutler, E., Gelbart, T. & Demina, A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl. Acad. Sci. U.S.A. 95, 8170\u20134 (1998).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"BFsrep06343_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0002-9610(99)80105-6","volume":"169","author":"MM Medley","year":"1995","unstructured":"Medley, M. M., Hooker, R. L., Rabinowitz, S., Holton, R. & Jaffe, B. M. Correction of congenital indirect hyperbilirubinemia by small intestinal transplantation. Am. J. Surg. 169, 20\u201327 (1995).","journal-title":"Am. J. Surg."},{"key":"BFsrep06343_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/mol.113.088112","volume":"84","author":"K Sumida","year":"2013","unstructured":"Sumida, K. et al. Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia. Mol. Pharmacol. 84, 679\u201386 (2013).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep06343_CR29","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3168\/jds.S0022-0302(05)73083-6","volume":"88","author":"KA Kr\u00fcger","year":"2005","unstructured":"Kr\u00fcger, K. A., Blum, J. W. & Greger, D. L. Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A. J. Dairy Sci. 88, 3971\u201381 (2005).","journal-title":"J. Dairy Sci."},{"key":"BFsrep06343_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/adc.56.7.568","volume":"56","author":"M de Carvalho","year":"1981","unstructured":"de Carvalho, M., Hall, M. & Harvey, D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch. Dis. Child. 56, 568\u20139 (1981).","journal-title":"Arch. Dis. Child."},{"key":"BFsrep06343_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1651-2227.1982.tb09515.x","volume":"71","author":"A Nicoll","year":"1982","unstructured":"Nicoll, A., Ginsburg, R. & Tripp, J. H. Supplementary feeding and jaundice in newborns. Acta. Paediatr. Scand. 71, 759\u201361 (1982).","journal-title":"Acta. Paediatr. Scand."},{"key":"BFsrep06343_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1124\/mol.62.3.638","volume":"62","author":"JM Maglich","year":"2002","unstructured":"Maglich, J. M. et al. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 62, 638\u2013646 (2002).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep06343_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1124\/mol.104.007161","volume":"67","author":"J Sugatani","year":"2005","unstructured":"Sugatani, J. et al. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor\/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol. Pharmacol. 67, 845\u2013855 (2005).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep06343_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11033-005-1750-9","volume":"33","author":"T Usui","year":"2006","unstructured":"Usui, T., Kuno, T. & Mizutani, T. Induction of human UDP-glucuronosyltransferase 1A1 by cortisol-GR. Mol. Biol. Rep. 33, 91\u201396 (2006).","journal-title":"Mol. Biol. Rep."},{"key":"BFsrep06343_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/dmd.106.013243","volume":"35","author":"K Senekeo-Effenberger","year":"2007","unstructured":"Senekeo-Effenberger, K. et al. Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor \u03b1 Activation. Drug Metab. Dispos. 35, 419\u201327 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"BFsrep06343_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/bj2760273","volume":"276","author":"JP Landers","year":"1991","unstructured":"Landers, J. P. & Bunce, N. J. The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276, 273\u2013287 (1991).","journal-title":"Biochem. J."},{"key":"BFsrep06343_CR37","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1074\/jbc.M610790200","volume":"282","author":"MF Yueh","year":"2007","unstructured":"Yueh, M. F. & Tukey, R. H. Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice. J. Biol. Chem. 282, 8749\u20138758 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06343_CR38","doi-asserted-by":"crossref","unstructured":"McDonagh, A. F. Bile pigments: bilatrienes and 5,15-biladienes. In: Dolphin D. (ed). The Porphyrins. New York, NY: Academic Press 293\u2013491 (1979).","DOI":"10.1016\/B978-0-12-220106-6.50013-9"},{"key":"BFsrep06343_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/bi00804a016","volume":"9","author":"R Tenhunen","year":"1970","unstructured":"Tenhunen, R., Ross, M. E., Marver, H. S. & Schmid, R. Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization. Biochemistry. 9, 298\u2013303 (1970).","journal-title":"Biochemistry."},{"key":"BFsrep06343_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0022-3476(77)80360-0","volume":"90","author":"LM Gartner","year":"1977","unstructured":"Gartner, L. M., Lee, K. S., Vaisman, S., Lane, D. & Zarafu, I. Development of bilirubin transport and metabolism in the newborn rhesus monkey. J Pediatr. 90, 513\u201331 (1977).","journal-title":"J Pediatr."},{"key":"BFsrep06343_CR41","unstructured":"Gartner, L. M. & Lane, D. L. The physiology of physiologic hyperbilirubinemia of the newborn. Medical primatology. 237\u2013247 (1972)."},{"key":"BFsrep06343_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1023\/A:1013794407325","volume":"12","author":"EH Temme","year":"2001","unstructured":"Temme, E. H., Zhang, J., Schouten, E. G. & Kesteloot, H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 12, 887\u2013894 (2001).","journal-title":"Cancer Causes Control."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep06343","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T11:42:11Z","timestamp":1717328531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep06343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep06343"],"URL":"https:\/\/doi.org\/10.1038\/srep06343","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,11]]},"assertion":[{"value":"2 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6343"}}